Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Emad, Elquza"'
Publikováno v:
Case Reports in Oncological Medicine, Vol 2018 (2018)
The low prevalence rate and limited literature on eccrine carcinoma (EC) pose a challenge to properly diagnosing and treating this rare malignancy. EC lesions tend to present similarly to other cutaneous neoplasms and dermatitis-like conditions. Effi
Externí odkaz:
https://doaj.org/article/c530d867e848408d83c1151aa10b5444
Autor:
Alejandro Recio Boiles, Ali McBride, Daniel O. Persky, Emad Elquza, Andrew S. Kraft, Cindy Banh, Alicia Ortega, Alejandra Arredondo, Kassie Notbohm, Hani M. Babiker, Kendall Valsvik
Publikováno v:
Supportive Care in Cancer
Purpose To characterize and compare both the outcome and cost of treatment of outpatient (OP) and inpatient (IP) ifosfamide therapy. Methods A single-center retrospective chart review of patients 18 years and older receiving ifosfamide therapy. The p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86f0f4eb9806051b9e6e858c02b82b56
http://europepmc.org/articles/PMC8617555
http://europepmc.org/articles/PMC8617555
Autor:
Nafisa Burhani, Hani M. Babiker, Emad Elquza, Andrea J. Bullock, Ely Benaim, Allyson J. Ocean, Lee G. Hicks, Peter J. Schlegel, Christine B. Peterson, Daruka Mahadevan, Mitesh J. Borad, Callie Heaton
Publikováno v:
Investigational New Drugs. 40:81-90
Background RX-3117 is an oral small molecule antimetabolite, cyclopentyl pyrimidyl nucleoside that is activated by cancer cells over-expressing uridine cytidine kinase 2 (UCK2). Single agent RX-3117 demonstrated efficacy in a phase I trial in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8841b5475e5beb9575ab758350b71ace
https://doi.org/10.1007/s10637-021-01164-9
https://doi.org/10.1007/s10637-021-01164-9
Autor:
Hassan Hatoum, Charles J. Link, Nicholas N. Vahanian, Noelle K. LoConte, Lodovico Balducci, Gabriela R. Rossi, Raed Al-Rajabi, John Seng, Eugene P. Kennedy, Nicholas Nissen, Joshua Banks, Warren S. Brenner, Thomas J. George, Benjamin L. Musher, Emad Elquza, Harish Lavu, Charles J. Yeo, Benjamin E. Leiby, Andrew L. Coveler, Gina M. Vaccaro, D Brock Hewitt
Publikováno v:
Hepatobiliary Surg Nutr
Objectives To compare the efficacy and safety of algenpantucel-L (HAPa; IND# 12311) immunotherapy combined with standard of care (SOC) chemotherapy and chemoradiation to SOC chemotherapy and chemoradiation therapy alone in patients with borderline re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a242a9659f405faa3d0bf5072d91ac2
https://doi.org/10.1097/sla.0000000000004669
https://doi.org/10.1097/sla.0000000000004669
Autor:
Aaron Scott, Hina Arif Tiwari, Kamil Hanna, Zana Alattar, Emad Elquza, Mohammad Hamidi, Oluwatosin P. Ayotunde, Agnes Ewongwo, Valentine Nfonsam
Publikováno v:
The American Journal of Surgery. 219:578-582
Introduction The aim of this study was to evaluate patient factors that contribute to increased incidence of early onset rectal cancer and analyze the short-term surgical outcomes of patients undergoing surgery. Methods A 2-year review (2015–2016)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fb63558b6b65ebb1c53ae9be506d1f2
https://doi.org/10.1016/j.amjsurg.2020.02.028
https://doi.org/10.1016/j.amjsurg.2020.02.028
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 7 (2015)
Hepatic epithelioid hemangioendothelioma (HEHE) is a rare, often misdiagnosed vascular neoplasm with clinical behaviors that range from indolent to highly aggressive. Even when the appropriate diagnosis is achieved, the best treatment for HEHE has no
Externí odkaz:
https://doaj.org/article/18ee36f1902145aea8315f59d9f306f0
Autor:
Hani, Babiker, Peter J, Schlegel, Lee G, Hicks, Andrea J, Bullock, Nafisa, Burhani, Daruka, Mahadevan, Emad, Elquza, Mitesh J, Borad, Ely, Benaim, Christine, Peterson, Callie, Heaton, Allyson J, Ocean
Publikováno v:
Investigational new drugs. 40(1)
Background RX-3117 is an oral small molecule antimetabolite, cyclopentyl pyrimidyl nucleoside that is activated by cancer cells over-expressing uridine cytidine kinase 2 (UCK2). Single agent RX-3117 demonstrated efficacy in a phase I trial in patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::651202fed5992602007b5c919335cd35
https://pubmed.ncbi.nlm.nih.gov/34417914
https://pubmed.ncbi.nlm.nih.gov/34417914
Autor:
Hunter Jecius, Jana Jandova, Jaroslav Janda, Landry Nfonsam, Pamela Omesiete, Emad Elquza, Aaron Scott, Valentine Nfonsam
Publikováno v:
Surgical Endoscopy. 34:3992-3998
Colon cancer (CC) is the third most commonly diagnosed cancer in the USA. While the overall incidence is declining, it is rising alarmingly in young patients (EOCC). CC in young patients tends to be more aggressive and often diagnosed at more advance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22dfb90c984b02573e7c8180da5665d9
https://doi.org/10.1007/s00464-019-07185-z
https://doi.org/10.1007/s00464-019-07185-z
Autor:
Jessica Vondrak, Ali McBride, Alejandro Recio-Boiles, Hitendra Patel, Hani M. Babiker, Rachna T. Shroff, Emad Elquza, Aaron Scott, Sumana Veeravelli
Publikováno v:
World Journal of Gastrointestinal Oncology
BACKGROUND Gastrointestinal cancer (GICA) is associated with a higher incidence of venous thromboembolism (VTE) compared to other solid tumors, moreover, recurrent VTE and major bleeding (MB) complications during anticoagulation treatment have an ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d6b419282c5f82c24b4ff16807e414c
https://doi.org/10.4251/wjgo.v11.i10.866
https://doi.org/10.4251/wjgo.v11.i10.866
Autor:
Hytham Hammad, Bobby Kalb, Emad Elquza, Hani M. Babiker, Alejandro Recio-Boiles, Krisha Howell, Aaron Scott, Valentine Nfonsam
Publikováno v:
Journal of Gastrointestinal Cancer. 51:254-259
An accurate clinical and radiological staging is the pyramid of treatment decisions in locally advanced rectal cancer (LARC). Guidelines recommended neoadjuvant chemoradiation therapy (CRT) followed by surgical resection for fit patients with LARC. D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::778c3b47c738cf2c7bc61d3443d61507
https://doi.org/10.1007/s12029-019-00246-5
https://doi.org/10.1007/s12029-019-00246-5